ATTORNEY NEWSLETTER A large Indian pharmaceutical manufacturer has agreed to settle with the United States and states’ attorneys general in a whistleblower lawsuit. The pharmaceutical manufacturer was alleged to have...
Category: Qui Tam
ATTORNEY NEWSLETTER In November of 2012 congress unanimously approved the passage of the whistleblowers could not protect themselves against associated retaliation by employers because of loopholes by the Federal Circuit...
ATTORNEY NEWSLETTER Exposing an organization’s misconduct or illegal activities requires courage. Employees who risk their professional careers by coming forward to report and help remedy illegal conduct are referred to...
ATTORNEY NEWSLETTER In the past, the Food and Drug Administration (FDA) took the lead role in investigating pharmaceutical manufacturing facilities for violations of good manufacturing practices (cGMP’s). Recently,...
ATTORNEY NEWSLETTER One lawsuit against Novartis alleges that the pharmaceutical company paid kickbacks to doctors to induce them to prescribe Novartis products over those from other companies. Those Novartis...